{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:27:18Z","timestamp":1777310838713,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Australian Government Department of Health: Drug and Alcohol Program"},{"name":"UNSW Scientia Fellowship"},{"name":"National Health and Medical Research Council Senior Research Fellowship","award":["1136908"],"award-info":[{"award-number":["1136908"]}]},{"name":"National Health and Medical Research Council Early Career Research Fellowships","award":["1119992"],"award-info":[{"award-number":["1119992"]}]},{"name":"National Health and Medical Research Council Early Career Research Fellowships","award":["1109366"],"award-info":[{"award-number":["1109366"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction and Aims<\/jats:title><jats:p>Pregabalin is a gamma\u2010aminobutyric acid analogue registered and subsidised for the treatment of neuropathic pain in Australia. Despite pre\u2010clinical evidence of low abuse potential, there are increasing reports of extramedical use and overdose deaths involving pregabalin. This study aimed to describe patterns of pregabalin use among an Australian sample of people who inject drugs (PWID) and identify sociodemographic, substance use and mental\/physical health correlates of prescribed and non\u2010prescribed use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Methods<\/jats:title><jats:p>Data were obtained from the 2018 Illicit Drug Reporting System, comprising a cross\u2010sectional sample of 905 PWID recruited from Australian capital cities. Multinomial logistic regression was used to identify correlates of past 6\u2010month prescribed and non\u2010prescribed pregabalin use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One\u2010quarter (25%) of participants reported any past 6\u2010month pregabalin use, with 10% reporting prescribed use and 15% non\u2010prescribed use. Past 6\u2010month use of prescribed benzodiazepines and non\u2010prescribed pharmaceutical opioids were associated with both prescribed and non\u2010prescribed pregabalin use compared to no recent pregabalin use. Pain\/discomfort on the day of interview was significantly associated with prescribed pregabalin use. Recent use of non\u2010prescribed benzodiazepines and illicit stimulants and past year non\u2010fatal overdose were significantly associated with non\u2010prescribed pregabalin use (compared to no recent pregabalin use).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Pregabalin use was relatively common among an Australian sample of PWID. Benzodiazepine and pharmaceutical opioid use were positively correlated with both prescribed and non\u2010prescribed pregabalin use, suggesting that education campaigns regarding the risks of harm associated with concomitant use of these substances are warranted (targeting both health professionals and consumers).<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13083","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:08:27Z","timestamp":1592388507000},"page":"568-574","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Patterns and correlates of prescribed and non\u2010prescribed pregabalin use among a sample of people who inject drugs in Australia"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5337-1751","authenticated-orcid":false,"given":"Rachel","family":"Sutherland","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-6234","authenticated-orcid":false,"given":"Paul M.","family":"Dietze","sequence":"additional","affiliation":[{"name":"Behaviours and Health Risks Burnet Institute  Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0452-8470","authenticated-orcid":false,"given":"Natasa","family":"Gisev","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[{"name":"Division of Psychology, School of Medicine University of Tasmania  Hobart Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Campbell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Memedovic","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2147"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0303-6"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00283.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0359-y"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14412"},{"key":"e_1_2_8_8_1","first-page":", 2017","volume-title":"Expenditure and prescriptions twelve months to 30 June 2017","author":"Rasalinkam R"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.12036"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1578-5"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.04.025"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12159"},{"key":"e_1_2_8_13_1","volume-title":"Australian drug trends 2018. Key findings from the National Illicit Drug Reporting System (IDRS) interviews","author":"Peacock A","year":"2018"},{"key":"e_1_2_8_14_1","first-page":"270","article-title":"Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis","volume":"38","author":"Iraurgi Castillo I","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02953.x"},{"key":"e_1_2_8_16_1","volume-title":"The alcohol use disorders identification test. Guidelines for use in primary care","author":"Babor TF","year":"2001"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.2001.tb00310.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000954"},{"key":"e_1_2_8_19_1","first-page":"705","article-title":"Changes in mood, depression and suicidal ideation after commencing pregabalin for neuropathic pain","volume":"43","author":"Hall TD","year":"2014","journal-title":"Aust Fam Physician"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0467-3"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1136"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13843"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00028-3"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.13083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13083","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:02:57Z","timestamp":1693951377000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/dar.13083"],"URL":"https:\/\/doi.org\/10.1111\/dar.13083","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"2019-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}